Aspen Neuroscience Inc.
ASPEHealthcare|Biotechnology|US
$12.44
+0.68 (+5.78%)
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06344026 Phase 1/2a Study of ANPD001 in Parkinson Disease | Parkinson Disease | P1 | By Invite | 9 | Open-label | ANPD001 |